Clinical predictors of advanced fibrosis in patient with non-alcoholic fatty liver disease (NAFLD)

被引：0
|
作者：
Siua, W. [1 ,2 ]
Andiganib, M. [1 ,2 ]
Frasera, A. [1 ,2 ]
Vijayana, B. [1 ,2 ]
Mclemana, L. [1 ,2 ]
Englisha, S. [1 ,2 ]
Mukhopadhyaa, A. [1 ,2 ]
机构：
[1] Aberdeen Royal Infirm, Aberdeen, Scotland
[2] Univ Aberdeen, Aberdeen, Scotland
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-0861
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [1] Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
    Olteanu, Vasile-Andrei
    Balan, Gheorghe G.
    Timofte, Oana
    Dascalu, Cristina Gena
    Gologan, Elena
    Gilca-Blanariu, Georgiana-Emanuela
    Diac, Madalina-Maria
    Sandu, Ion
    Stefanescu, Gabriela
    DIAGNOSTICS, 2022, 12 (09)
  • [2] Predictors of Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
    Pagadala, Mangesh
    Zein, Claudia O.
    McCullough, Arthur J.
    CLINICS IN LIVER DISEASE, 2009, 13 (04) : 591 - +
  • [3] Independent Predictors of Non-alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in a Large Cohort of Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
    Fang, Yun
    Rafiq, Nila
    Afendy, Mariam
    Younossi, Youssef
    Lam, Brian
    Goodman, Zachary
    Younossi, Zobair
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S120 - S120
  • [4] Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Majid, Zain
    TROPICAL DOCTOR, 2018, 48 (02) : 107 - 112
  • [5] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    LABORATORY INVESTIGATION, 2003, 83 (01) : 283A - 283A
  • [6] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    MODERN PATHOLOGY, 2003, 16 (01) : 283A - 283A
  • [7] Predictors of non-alcoholic steatohepatitis and fibrosis in non-alcoholic fatty liver disease.
    Pong, JP
    Elariny, H
    Younoszai, A
    HEPATOLOGY, 2002, 36 (04) : 407A - 407A
  • [8] SARCOPENIA AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH ADVANCED FIBROSIS
    Golabi, Pegah
    Paik, James M.
    Cable, Rebecca
    Racila, Andrei
    Srishord, Manirath
    Younossi, Zobair M.
    HEPATOLOGY, 2021, 74 : 1039A - 1039A
  • [9] Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Verma, Siddharth
    Jensen, Donald
    Hart, John
    Mohanty, Smruti R.
    LIVER INTERNATIONAL, 2013, 33 (09) : 1398 - 1405
  • [10] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
12345